icon-circle-smiley-face

News Links

Press Releases and Product Information May 11, 2022

Sun Life U.S. renews partnership with American Diabetes Association as national sponsor of Project Power youth fitness and health program

Read More

Popular Press News for May 11, 2022

EPIC Diabetes Conference Provides Practical Patient Care Advice Diabetes: America’s growing health care crisis Your Health: A new approach to type-1 diabetes Outcomes worse for children with type 1 diabetes who are Black Changes to Alberta’s Type 1 diabetes insulin pump coverage trigger concern over lack of details, increased costs U of A researchers hope new treatment can help children battle diabetes Obesity Could Raise a Child’s Odds for Type 1 Diabetes Type 1 diabetes: ‘People don’t know how hard it is’

Read More

Social Media Links for May 11, 2022

Skin Care Tips For People With Diabetes A Child of Diabetes Yes, I lied about my blood sugar levels as a teenager with diabetes Despite Universal Healthcare, Diabetes Disparities Persist in the United Kingdom DIABETES AND STATINS Supporting a Loved One with Type 1 Diabetes The Biggest News in Diabetes Technology: Highlights from ATTD 2022 Tips for Talking to your Teenager with Diabetes: Avoiding Shame + Blame The ILet Bionic Pancreas is the Next Step in Autonomous Insulin Therapy

Read More

Research News for May 11, 2022

FDA places hold on trial of novel cell therapy for type 1 diabetes Recombinant human glutamic acid decarboxylase may preserve C-peptide in type 1 diabetes Identification of miRNA-mRNA-TF regulatory networks in peripheral blood mononuclear cells of type 1 diabetes Recent Advances in Immune-based Therapies for Type 1 Diabetes Towards the Integration of an Islet-Based Biosensor in Closed-Loop Therapies for Patients With Type 1 Diabetes (Full text HTML, PDF) rs3806265 and rs4612666 of the NLRP3 Gene Are Associated With the Titer of Glutamic Acid Decarboxylase Antibody in Type 1 Diabetes (Full text HTML, PDF) Host gene effects on gut microbiota in […]

Read More

Daily Care News for May 11, 2022

Black Kids From Poorer Neighborhoods Hit Hardest by DKA Readmissions Depression and Anxiety Reported in Teens with Type 1 Diabetes Symptoms and Glycemic Control in Young People with Type 1 Diabetes following SARS-CoV-2 Infection: an Observational Study Diabetic Ketoacidosis Rates Increased During COVID-19 Pandemic in Patients With Type 1 Diabetes Diabetes Screening Thresholds Should Be Lowered for Racial Minorities Extended-wear insulin infusion set lasts 7 days for most wearers, with few adverse events Differential prognostic burden of cardiovascular disease and lower-limb amputation on the risk of all-cause death in people with long-standing type 1 diabetes Precision diagnostic approach to predict […]

Read More

Legislative and Policy News for May 4, 2022

Out-of-pocket spending on insulin among people with private insurance

Read More

Celiac News for May 4, 2022

Celiac Disease More Prevalent in Patients With Juvenile Idiopathic Arthritis Celiac Disease Associated With Sexual Dysfunction In Males As Well As Females: Study Your Good Health: Get celiac diagnosis before cutting out gluten Top in GI: Celiac disease management; nocturnal gastroesophageal reflux May is Celiac Awareness Month New Center for Pediatric IBD and Celiac Disease Best gluten free cookbooks: Tasty recipes to try in 2022 Case Report: Fulminant Celiac Disease With Combination Immune Checkpoint Therapy (Full text HTML, PDF) Ultra-short celiac disease exhibits differential genetic and immunophenotypic features compared to conventional celiac disease Prediction models for celiac disease development in […]

Read More

Press Releases and Product Information May 4, 2022

Abbott, Camdiab and Ypsomed Unveil New Automated Insulin Delivery Partnership for People with Diabetes New Analysis Shows that Abbott’s Freestyle Libre System Provides Similar and Sustained Reductions in Glucose Levels For People with Both Type 1 and Type 2 Diabetes Dexcom study shows strong accuracy for next-gen G7 CGM in pediatric T1D patients The iLet® Bionic Pancreas Significantly Reduced HbA1c and Improved Time in Range vs Standard of Care for a Diverse Range of People with Type 1 Diabetes Vertex Provides Updates on Phase 1/2 Clinical Trial of VX-880 for the Treatment of Type 1 Diabetes Walmart launches virtual diabetes […]

Read More

Popular Press News for May 4, 2022

Type 1 Diabetes: Interview with Dr. Kannan Kasuri Diabetes clinical trials located in few socially disadvantaged counties in US Mother says son’s insulin continues to be administered improperly at school FDA suspends early study of Vertex stem-cell therapy for type 1 diabetes

Read More

Social Media Links for May 4, 2022

Putting Time in Range at the Forefront of Clinical Trials Women’s Health & Diabetes Technology – The Latest ATTD: CGMs, Automated Insulin Delivery, and Provider Biases Menopause: Advice for Women on Health, Healthy Eating, Hormones and More Comprehensive Approaches to Addressing Hypoglycemia Vertex Provides an Update on the VX-880 Clinical Trial

Read More